Eli Lilly (NYSE: LLY) is encouraged by trial data for its latest weight-loss and diabetes medications. Where to invest $1,000 ...

which tends to hurt stock performance. The strategy also had less exposure to highly liquid stocks compared with Morningstar Category peers in recent months. Less-liquid stocks might offer strong ...